Juno Therapeutics Inc. buy melinda
Start price
06.12.17
/
50%
€48.38
Target price
20.12.17
€55.92
Performance (%)
-17.88%
End price
20.12.17
€39.73
Summary
This prediction ended on 20.12.17 with a price of €39.73. The price of Juno Therapeutics Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -17.88%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Juno Therapeutics Inc. | - | - | - | - |
iShares Core DAX® | 1.887% | 1.967% | 17.000% | 18.227% |
iShares Nasdaq 100 | 2.316% | -1.227% | 22.986% | 35.321% |
iShares Nikkei 225® | 1.134% | 0.390% | 9.520% | -0.898% |
iShares S&P 500 | 1.821% | 0.790% | 22.957% | 39.161% |
Comments by melinda for this prediction
In the thread Juno Therapeutics Inc. diskutieren
2017.11.12 Die aktualisierten Daten aus Phase 1 werden 11, bei ASH Dezember 2017 vorgelegt werden.
r / r Non-Hodgkin-B-Zell - Lymphom - Krebs
Phase 1/2
(Vom Mitglied beendet)
Stopped prediction by melinda for Juno Therapeutics Inc.
Juno Therapeutics Inc.
Start price
Target price
Perf. (%)
€43.69
05.01.18
05.01.18
€56.38
17.01.18
17.01.18
39.54%
17.01.18
17.01.18
Juno Therapeutics Inc.
Start price
Target price
Perf. (%)
€27.85
14.07.16
14.07.16
€44.20
16.01.17
16.01.17
-35.22%
16.01.17
16.01.17